Holding(s) in Company
Genesis Emerging Markets Fund Ld
For filings with the FSA include the annex | Â | Â | Â | Â | Â | |||||||||||
For filings with issuer exclude the annex | ||||||||||||||||
 | ||||||||||||||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | ||||||||||||||||
 |  |  |  |  | ||||||||||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
Genesis Emerging Markets Fund Limited | Â | ||||||||||||||
2 Reason for the notification (please tick the appropriate box or boxes): | Â | |||||||||||||||
An acquisition or disposal of voting rights |
X |
|||||||||||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | Â | |||||||||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | Â | |||||||||||||||
An event changing the breakdown of voting rights | Â | |||||||||||||||
Other (please specify): | Â | Â | ||||||||||||||
3. Full name of person(s) subject to the notification obligation: iii |
 | BlackRock, Inc. | ||||||||||||||
4. Full name of shareholder(s) (if different from 3.):iv |
 | |||||||||||||||
5. Date of the transaction and date on which the threshold is crossed or reached: v |
27th July 2012 | |||||||||||||||
6. Date on which issuer notified: | 31st July 2012 | |||||||||||||||
7. Threshold(s) that is/are crossed or reached: vi, vii |
Holding has gone above 22% |
8. Notified details: | |||||||||||||||||||||||||||||||||||
A: Voting rights attached to shares viii, ix | |||||||||||||||||||||||||||||||||||
Class/type of shares
|
 |
Situation previous to the triggering transaction |
 | Resulting situation after the triggering transaction | |||||||||||||||||||||||||||||||
Number of Shares |
 |
Number of Voting Rights |
Number of shares |
 |
Number of voting rights |
 | % of voting rights x | ||||||||||||||||||||||||||||
Direct | Direct xi | Â | Indirect xii | Direct | Â | Indirect | |||||||||||||||||||||||||||||
GG00B4L0PD47 | 25,802,865 | 25,802,865 | N/A | N/A | 30,846,265 | N/A | 22.86% | ||||||||||||||||||||||||||||
 | |||||||||||||||||||||||||||||||||||
B: Qualifying Financial Instruments | |||||||||||||||||||||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||||||||||||||||||||
Type of financial instrument |
 |
Expiration date xiii |
 |
Exercise/ Conversion Period xiv |
 |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
 |
% of voting rights |
|||||||||||||||||||||||||||
 |  |  |  |  | |||||||||||||||||||||||||||||||
 | |||||||||||||||||||||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | |||||||||||||||||||||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||||||||||||||||||||
Type of financial instrument |
 | Exercise price |  | Expiration date xvii |  |
Exercise/ Conversion period xviii |
 | Number of voting rights instrument refers to |  | % of voting rights xix, xx | |||||||||||||||||||||||||
 |  |  |  |  | Nominal |  | Delta | ||||||||||||||||||||||||||||
 |  | ||||||||||||||||||||||||||||||||||
 | |||||||||||||||||||||||||||||||||||
Total (A+B+C) | |||||||||||||||||||||||||||||||||||
Number of voting rights | Percentage of voting rights | ||||||||||||||||||||||||||||||||||
30,846,265 | 22.86% |
9. Chain of controlled undertakings through which the voting
rights and/or the financial instruments are effectively held, if applicable: xxi |
|||||
BlackRock Investment Management (UK) Limited – 30,846,265 (22.86%) |
|||||
 | |||||
Proxy Voting: | |||||
10. Name of the proxy holder: | Â | Â | |||
11. Number of voting rights proxy holder will cease to hold: |
 | ||||
12. Date on which proxy holder will cease to hold voting rights: |
 | ||||
 | |||||
13. Additional information: |
 | BlackRock International Threshold Reporting Team | |||
14. Contact name: |
William Graham |
||||
15. Contact telephone number: | 020 7743 1459 |